Bullous pemphigoid: What's ahead?

Masutaka Furue, Takafumi Kadono

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Bullous pemphigoid (BP) is an autoimmune subepidermal blistering skin disease mainly affecting older individuals. Pathogenic autoantibodies preferentially target the non-collagenous 16A domain of collagen XVII (also called BP antigen 2, BPAG2) present in hemidesmosomes. The pathogenic anti-BPAG2 antibodies cause the dermal-epidermal separation in neonatal and adult mice as well as in cryosections of human skin. These experimental BP models stress a pivotal role for neutrophils and the Fcγ receptor of immunoglobulins. Mice that have been genetically manipulated in the pathogenic domain of BPAG2 spontaneously develop subepidermal blistering with pruritus and eosinophilic infiltration. BPAG2 is physiologically and aberrantly expressed in neuronal tissue and internal malignancies, and the associations of BP with Parkinson's disease, stroke and internal malignancies invites new investigations into the immunological dysregulation behind the comorbidity.

Original languageEnglish
Pages (from-to)237-240
Number of pages4
JournalJournal of Dermatology
Volume43
Issue number3
DOIs
Publication statusPublished - Mar 1 2016

Fingerprint

Bullous Pemphigoid
Antigens
Hemidesmosomes
Immunoglobulin Fc Fragments
Skin
Fc Receptors
Pruritus
Skin Diseases
Autoantibodies
Parkinson Disease
Comorbidity
Neoplasms
Neutrophils
Stroke
Antibodies

All Science Journal Classification (ASJC) codes

  • Dermatology

Cite this

Bullous pemphigoid : What's ahead? / Furue, Masutaka; Kadono, Takafumi.

In: Journal of Dermatology, Vol. 43, No. 3, 01.03.2016, p. 237-240.

Research output: Contribution to journalReview article

Furue, Masutaka ; Kadono, Takafumi. / Bullous pemphigoid : What's ahead?. In: Journal of Dermatology. 2016 ; Vol. 43, No. 3. pp. 237-240.
@article{1692c550cc254963a0462e4665a85edb,
title = "Bullous pemphigoid: What's ahead?",
abstract = "Bullous pemphigoid (BP) is an autoimmune subepidermal blistering skin disease mainly affecting older individuals. Pathogenic autoantibodies preferentially target the non-collagenous 16A domain of collagen XVII (also called BP antigen 2, BPAG2) present in hemidesmosomes. The pathogenic anti-BPAG2 antibodies cause the dermal-epidermal separation in neonatal and adult mice as well as in cryosections of human skin. These experimental BP models stress a pivotal role for neutrophils and the Fcγ receptor of immunoglobulins. Mice that have been genetically manipulated in the pathogenic domain of BPAG2 spontaneously develop subepidermal blistering with pruritus and eosinophilic infiltration. BPAG2 is physiologically and aberrantly expressed in neuronal tissue and internal malignancies, and the associations of BP with Parkinson's disease, stroke and internal malignancies invites new investigations into the immunological dysregulation behind the comorbidity.",
author = "Masutaka Furue and Takafumi Kadono",
year = "2016",
month = "3",
day = "1",
doi = "10.1111/1346-8138.13207",
language = "English",
volume = "43",
pages = "237--240",
journal = "Journal of Dermatology",
issn = "0385-2407",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Bullous pemphigoid

T2 - What's ahead?

AU - Furue, Masutaka

AU - Kadono, Takafumi

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Bullous pemphigoid (BP) is an autoimmune subepidermal blistering skin disease mainly affecting older individuals. Pathogenic autoantibodies preferentially target the non-collagenous 16A domain of collagen XVII (also called BP antigen 2, BPAG2) present in hemidesmosomes. The pathogenic anti-BPAG2 antibodies cause the dermal-epidermal separation in neonatal and adult mice as well as in cryosections of human skin. These experimental BP models stress a pivotal role for neutrophils and the Fcγ receptor of immunoglobulins. Mice that have been genetically manipulated in the pathogenic domain of BPAG2 spontaneously develop subepidermal blistering with pruritus and eosinophilic infiltration. BPAG2 is physiologically and aberrantly expressed in neuronal tissue and internal malignancies, and the associations of BP with Parkinson's disease, stroke and internal malignancies invites new investigations into the immunological dysregulation behind the comorbidity.

AB - Bullous pemphigoid (BP) is an autoimmune subepidermal blistering skin disease mainly affecting older individuals. Pathogenic autoantibodies preferentially target the non-collagenous 16A domain of collagen XVII (also called BP antigen 2, BPAG2) present in hemidesmosomes. The pathogenic anti-BPAG2 antibodies cause the dermal-epidermal separation in neonatal and adult mice as well as in cryosections of human skin. These experimental BP models stress a pivotal role for neutrophils and the Fcγ receptor of immunoglobulins. Mice that have been genetically manipulated in the pathogenic domain of BPAG2 spontaneously develop subepidermal blistering with pruritus and eosinophilic infiltration. BPAG2 is physiologically and aberrantly expressed in neuronal tissue and internal malignancies, and the associations of BP with Parkinson's disease, stroke and internal malignancies invites new investigations into the immunological dysregulation behind the comorbidity.

UR - http://www.scopus.com/inward/record.url?scp=84962030240&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962030240&partnerID=8YFLogxK

U2 - 10.1111/1346-8138.13207

DO - 10.1111/1346-8138.13207

M3 - Review article

C2 - 26603373

AN - SCOPUS:84962030240

VL - 43

SP - 237

EP - 240

JO - Journal of Dermatology

JF - Journal of Dermatology

SN - 0385-2407

IS - 3

ER -